Dr. Michael Osofsky, MD

NPI: 1376706945
Total Payments
$284.85
2024 Payments
$33.83
Companies
4
Transactions
16
Medicare Patients
3,821
Medicare Billing
$259,689

Payment Breakdown by Category

Food & Beverage$284.85 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $284.85 16 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $151.90 8 $0 (2024)
Janssen Biotech, Inc. $88.98 6 $0 (2020)
GlaxoSmithKline, LLC. $25.07 1 $0 (2021)
Dermavant Sciences, Inc. $18.90 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $33.83 2 ABBVIE INC. ($33.83)
2023 $32.20 2 Dermavant Sciences, Inc. ($18.90)
2022 $61.30 3 ABBVIE INC. ($61.30)
2021 $68.54 3 AbbVie Inc. ($43.47)
2020 $12.69 1 Janssen Biotech, Inc. ($12.69)
2019 $76.29 5 Janssen Biotech, Inc. ($76.29)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
11/11/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $14.59 General
Category: IMMUNOLOGY
08/20/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $19.24 General
Category: IMMUNOLOGY
06/12/2023 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $13.30 General
Category: IMMUNOLOGY
03/02/2023 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $18.90 General
Category: DERMATOLOGY
03/11/2022 ABBVIE INC. HUMIRA (Biological) Food and Beverage In-kind items and services $16.82 General
Category: IMMUNOLOGY
02/28/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $22.25 General
Category: IMMUNOLOGY
02/10/2022 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $22.23 General
Category: IMMUNOLOGY
09/22/2021 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $27.53 General
Category: IMMUNOLOGY
04/30/2021 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $15.94 General
Category: IMMUNOLOGY
02/10/2021 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $25.07 General
Category: IMMUNOLOGY
03/03/2020 Janssen Biotech, Inc. REMICADE (Biological), STELARA, SIMPONI Food and Beverage In-kind items and services $12.69 General
Category: Immunology
12/02/2019 Janssen Biotech, Inc. SIMPONI (Biological) Food and Beverage In-kind items and services $16.08 General
Category: Immunology
11/04/2019 Janssen Biotech, Inc. SIMPONI (Biological) Food and Beverage In-kind items and services $15.05 General
Category: Immunology
09/04/2019 Janssen Biotech, Inc. SIMPONI (Biological) Food and Beverage In-kind items and services $13.00 General
Category: Immunology
07/29/2019 Janssen Biotech, Inc. SIMPONI (Biological) Food and Beverage In-kind items and services $16.08 General
Category: Immunology
05/31/2019 Janssen Biotech, Inc. SIMPONI (Biological) Food and Beverage In-kind items and services $16.08 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 1,254 1,934 $199,165 $81,461
2022 11 1,188 1,887 $175,560 $77,631
2021 12 814 1,212 $122,495 $61,149
2020 11 565 882 $84,395 $39,447
Total Patients
3,821
Total Services
5,915
Medicare Billing
$259,689
Procedure Codes
47

All Medicare Procedures & Services

47 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 389 448 $57,475 $26,606 46.3%
17110 Destruction of skin growth, 1-14 growths Office 2023 119 131 $21,950 $10,352 47.2%
17000 Destruction of precancer skin growth, 1 growth Office 2023 217 246 $29,520 $9,800 33.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 69 92 $15,605 $8,250 52.9%
11102 Biopsy of related skin growth, first growth Office 2023 98 106 $15,570 $7,202 46.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 98 98 $14,520 $6,484 44.7%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 21 26 $7,150 $3,295 46.1%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 149 679 $23,765 $3,160 13.3%
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm Office 2023 12 14 $3,360 $1,700 50.6%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2023 24 24 $2,610 $1,209 46.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 31 32 $2,920 $1,184 40.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 11 11 $2,290 $1,169 51.0%
11103 Biopsy of related skin growth, each additional growth Office 2023 16 27 $2,430 $1,052 43.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 344 407 $46,425 $25,278 54.5%
17110 Destruction of skin growth, 1-14 growths Office 2022 110 130 $19,500 $9,779 50.1%
17000 Destruction of precancer skin growth, 1 growth Office 2022 204 228 $27,360 $8,888 32.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 117 117 $16,380 $8,482 51.8%
11102 Biopsy of related skin growth, first growth Office 2022 105 114 $13,680 $7,799 57.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 54 79 $13,035 $6,775 52.0%
17004 Destruction of precancer skin growth, 15 or more growths Office 2022 23 26 $7,150 $3,400 47.6%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 143 688 $24,080 $3,385 14.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 46 49 $3,670 $1,755 47.8%
99202 New patient office or other outpatient visit, 15-29 minutes Office 2022 24 24 $2,280 $1,086 47.6%
11103 Biopsy of related skin growth, each additional growth Office 2022 18 25 $2,000 $1,005 50.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 205 265 $27,545 $17,079 62.0%

About Dr. Michael Osofsky, MD

Dr. Michael Osofsky, MD is a Dermatology healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376706945.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Osofsky, MD has received a total of $284.85 in payments from pharmaceutical and medical device companies, with $33.83 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($284.85).

As a Medicare-enrolled provider, Osofsky has provided services to 3,821 Medicare beneficiaries, totaling 5,915 services with total Medicare billing of $259,689. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Coraopolis, PA
  • Active Since 07/03/2008
  • Last Updated 09/26/2019
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1376706945

Products in Payments

  • SKYRIZI (Biological) $90.60
  • SIMPONI (Biological) $76.29
  • RINVOQ (Biological) $44.48
  • BENLYSTA (Biological) $25.07
  • VTAMA (Drug) $18.90
  • HUMIRA (Biological) $16.82
  • REMICADE (Biological) $12.69

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Coraopolis